| 1 |
32781837 | Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of metastatic breast cancer. | 2020 Nov |
1 |
| 2 |
31875784 | Molecular Dynamics Mechanisms of the Inhibitory Effects of Abemaciclib, Hymenialdisine, and Indirubin on CDK-6. | 2019 |
1 |
| 3 |
27748766 | Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence. | 2017 Apr 20 |
1 |
| 4 |
24850847 | Semi-mechanistic pharmacokinetic/pharmacodynamic modeling of the antitumor activity of LY2835219, a new cyclin-dependent kinase 4/6 inhibitor, in mice bearing human tumor xenografts. | 2014 Jul 15 |
2 |
| 5 |
24919854 | Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine. | 2014 Oct |
1 |